Patent · US Active

Bacitracin antibiotics

US8410044B2 · kind B2 · utility

1Cited by

0References

15Claims

0Family size

Assignee

Xellia Pharmaceuticals ApS · DK

Inventors

Martin Mansson · Oslo, NO
Christine Senstad · Sandefjord, NO

Key dates

Filing date	Sep 30, 2010
Grant date	Apr 2, 2013
Priority date	—
Expiry date	Sep 30, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns new Bacitracin compounds containing methylene-isoleucine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.